Skip To Main Content
For US Healthcare Professionals

Diabetic Macular Edema (DME)

Financial support

Committed to helping you find assistance options for VABYSMO

There may be options to help you afford VABYSMO, no matter what type of health insurance you have or even if you don’t have health insurance.

Use our Patient Assistance Tool to find out what you might be eligible for.

  • Do you have health insurance?

  • Does your health insurance cover your Genentech treatment?

  • Do you have commercial health insurance?

  • Are you already getting financial assistance to help pay for your treatment?

  • Are you taking VABYSMO for an FDA-approved use?

You Might Qualify for a Referral to the Genentech Ophthalmology Co-pay Program

If you have commercial health insurance, VABYSMO Access Solutions can refer you to the Genentech Ophthalmology Co-pay Program. It can help you with the out-of-pocket costs of your Genentech treatment, if you’re eligible.*

 

Learn More

 

*Eligibility criteria apply. Not valid for patients using federal or state government programs to pay for their medications and/or administration of their Genentech medication. Patient must be taking the Genentech medication for an FDA-approved indication. See full Terms and Conditions at EyeOnCopay.com.

You Might Qualify for a Referral to an Independent Co-pay Assistance Foundation

If you need help with your co-pay for your Genentech treatment, we can refer you to an independent co-pay assistance foundation.*

 

Learn More

 

*These organizations are independent of Genentech and may require you to provide personal or financial information to enroll in their programs. Genentech cannot share any information you have provided to us.

Independent co-pay assistance foundations have their own rules for eligibility. We have no involvement or influence in independent foundation decision-making or eligibility criteria and do not know if a foundation will be able to help you. We can only refer to you a foundation that supports your disease state. This information is provided as a resource for you. We do not endorse or show preference for any particular foundation. The foundations in this list may not be the only ones that might be able to help you.

You Might Qualify for a Referral to the Genentech Patient Foundation

The Genentech Patient Foundation provides free Genentech treatment to people who don't have insurance coverage or who have financial concerns and meet eligibility criteria.*

 

Learn More

 

*If you have health insurance, you should try to get other types of financial assistance, if available. You also need to meet income requirements. If you do not have insurance, or if your insurance does not cover your Genentech treatment, you must meet a different set of income requirements.

VABYSMO Co-pay Program (icon)

Genentech Ophthalmology Co-pay Program*

The Genentech Ophthalmology Co-pay Program helps eligible people who have commercial health insurance with the out-of-pocket costs for VABYSMO.

LEARN MORE
Independent Co-pay Assistance Foundation (icon)

Independent Co-pay Assistance Foundations†

If you need help with the co-pay for VABYSMO, Genentech Ophthalmology Access Solutions can refer you to an independent co-pay assistance foundation. This is a charitable organization that gives financial assistance for treatments.

HOW WE CAN HELP
Genentech Patient Foundation (icon)

The Genentech Patient Foundation‡

If you don’t have insurance coverage or have financial concerns and meet eligibility criteria, you may be able to get free treatment from the Genentech Patient Foundation.

DO YOU QUALIFY?

Want to learn more?

The Genentech Ophthalmology Support Line makes it easy for you to quickly access the information and support you need.

Just call (833) EYE-GENE/(833) 393-4363 and one of our representatives will be with you soon. Our representatives are available Monday-Friday, 9 am - 8 pm ET.

*Eligibility criteria apply. Not valid for patients using federal or state government programs to pay for their medications and or administration of their Genentech medication. Patient must be taking the Genentech medication for an FDA-approved indication. See full Terms and Conditions at EyeOnCopay.com.

†Independent co-pay assistance foundations have their own rules for eligibility. We cannot guarantee a foundation will help you. We only can refer you to a foundation that supports your disease state. We do not endorse or show financial preference for any particular foundation. The foundations we refer you to are not the only ones that might be able to help you.

‡If you have health insurance, you should try to get other types of financial assistance, if available. You also need to meet income requirements. If you do not have insurance, or if your insurance does not cover your Genentech medicine, you must meet a different set of income requirements.

What is VABYSMO?

VABYSMO (faricimab-svoa) is a prescription medicine given by injection into the eye, used to treat adults with Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).

Do not receive VABYSMO if you:

  • have an infection in or around your eye. 
  • have active swelling around your eye that may include pain and redness. 
  • are allergic to VABYSMO or any of the ingredients in VABYSMO.

What is the most important information I should know about VABYSMO?

  • Injections like the one for VABYSMO can cause an eye infection (endophthalmitis) or separation of layers of the retina (retinal detachment). Call your healthcare provider right away if you have increasing eye pain, vision loss, sensitivity to light, or redness in the white of the eye.
  • VABYSMO may cause a temporary increase in pressure in the eye (intraocular pressure), which occurs 60 minutes after the injection. 
  • Although not common, VABYSMO patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes (thromboembolic events). In clinical studies for wet AMD during the first year, 7 out of 664 patients treated with VABYSMO reported such an event. In DME studies during the first year, 25 out of 1,262 patients treated with VABYSMO reported such an event.

Before receiving VABYSMO, tell your healthcare provider about all of your medical conditions, including if you:

  • Are pregnant or plan to become pregnant. Based on how VABYSMO interacts with your body, there may be a potential risk to your unborn baby. You should use birth control before your first injection, during your treatment with VABYSMO, and for 3 months after your last dose of VABYSMO. 
  • Are breastfeeding or plan to breastfeed. It is not known if VABYSMO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you receive VABYSMO.
  • Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What should I avoid while receiving VABYSMO? 

  • Your vision may be impaired after receiving an eye injection or after an eye exam; do not drive or use machinery until your vision has recovered sufficiently.  

What are the most common side effects with VABYSMO?

  • The most common side effect with VABYSMO was blood on the white of the eye (conjunctival hemorrhage).
  • These are not all the possible side effects of VABYSMO. 

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. 

Please see the VABYSMO full Prescribing Information for additional Important Safety Information.